Actualités Portugal - Le premier fonds de biotechnologie portugais, Biovance Capital Partners, a levé 51 millions d’euros.

Portugal news - Portugal’s first biotech VC, Biovance Capital Partners, raised 51 million euros, marking the first investment by the EIF.

Portugal’s Prime Minister proposed a new Start-up Law on December 22nd.

According to a study by Venture Capital firm Atomico, investment in European Tech is expected to reach $85B in 2022.